Pesquisa de Pacientes
Entrar
Todos os estudos
Inscrição por conviteOBSERVACIONAL

RegisterPROS - a Registry for Prostate Cancers

The RegisterPROS study is building a confidential registry of men who have prostate cancer. Researchers want to gather information and blood samples from patients to learn more about the disease. They are especially interested in new, simpler blood tests, such as one called PROSTest, that might help doctors diagnose prostate cancer earlier, track its progress, and see if treatments are working. By collecting this information, the study hopes to improve how prostate cancer is detected, monitored, and treated in the future, ultimately leading to better care for patients. All data is kept private.

Em resumo

Status
Inscrição por convite
Patrocinador
Wren Laboratories LLC
Meta de inscrição
1,000
Iniciar
15 Jan 2020
Conclusão estimada
15 Dec 2030
Câncer de Próstata (Adenocarcinoma)Prostate BiopsyProstatectomyRadioligandQuimioterapiaAndrogen Deprivation TherapyPSA

Sobre o que é este estudo?

Prostate cancer starts in a small gland in men called the prostate. There are many ways to treat it, including surgery, medicines, and radiation. Doctors know that finding prostate cancer early and accurately, or catching when it comes back or treatments stop working, can make a big difference in how well men do.

Currently, there are tests like PSA (Prostate-Specific Antigen) that help, but doctors are always looking for even better ways to check for prostate cancer without needing invasive procedures. They also want to understand if certain tests can help predict which treatments will work best for individual patients.

That's where the RegisterPROS study comes in. It's collecting information and blood samples from men with prostate cancer from different places like Europe, Africa, the Caribbean, and the USA. The aim is to build a large database to study how good new blood tests, like one called PROSTest, are at finding prostate cancer and tracking it over time. The study will also look at how different treatments work and what happens with the disease, to give doctors more information to help their patients.

Pontos principais

  • RegisterPROS is building a database about prostate cancer.
  • It aims to improve diagnosis and monitoring using new blood tests like PROSTest.
  • The study collects anonymised data and samples from men with prostate cancer.
  • It could lead to better future treatments and understanding of the disease.
  • Participation involves sharing medical information and providing blood/saliva samples.
  • Your personal information will be kept private.

Quem pode ser elegível?

This study is looking for men who have been diagnosed with prostate cancer. You would need to have had a biopsy that confirmed you have the disease.

Generally, participants should be between 45 and 100 years old. The study is open to all men who fit the diagnosis criteria within this age range.

Este estudo pode ser adequado para você?

Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.

  1. I am a male.
  2. I have been diagnosed with prostate cancer.
  3. My prostate cancer diagnosis was confirmed with a biopsy.
  4. I am between 45 and 100 years old.
Responda a todas as perguntas para ver o seu resultado.

O que envolve a participação?

If you decide to take part in RegisterPROS, your doctor will collect some information about your health and your prostate cancer. They will also take blood and saliva samples from you. This information and your samples will be sent to the study in a way that keeps your identity private. The study will then follow your progress over time, checking how your condition is doing and how well any treatments are working. You and your doctor would decide how long you participate, as this depends on your ongoing care, but your data would be regularly evaluated within the study.

Riscos e benefícios potenciais

Taking part in this study may not directly benefit you, but the information collected could help improve prostate cancer care for future patients. There are minimal risks involved, mainly from having blood and saliva samples taken, which are standard procedures. You are free to withdraw from the study at any time without affecting your medical care.

Localizações (1)

  • University Hospital Munster
    Código postal verificado
    Münster, Germany

Perguntas frequentes

What is the main goal of the RegisterPROS study?

The main goal is to create a large database of information and samples from men with prostate cancer to find better ways to diagnose and monitor the disease, especially with new simple blood tests.

What is PROSTest?

PROSTest is an example of a new type of blood test that the study is looking at to see if it can help doctors detect and track prostate cancer more effectively than current methods.

Will my personal details be kept private?

Yes, all data collected for the study will be anonymised, meaning your name and other identifying information will be removed to protect your privacy.

Do I have to change my prostate cancer treatment if I join?

No, joining this registry will not require you to change your existing prostate cancer treatment plan. Your doctors will continue to manage your care as usual.

Por quanto tempo estarei envolvido no estudo?

Your involvement typically aligns with your ongoing medical appointments for prostate cancer. Information will be collected regularly, but you can discuss the exact duration with your doctor.

Como saber mais

Registro oficial do julgamento

Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.

Interessado em participar?

Registre seu interesse

Compartilhe seus detalhes e a equipe de pesquisa para "RegisterPROS - a Registry for Prostate Cancers…" entrará em contato com você se você for elegível. Sempre fale com seu médico antes de concordar em participar.

Discussão

Discussão da comunidade

Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.